首页> 外国专利> Use of apoptosis-specific EIF-5A sirnas for the manufacture of a medicament for use in the treatment of a disease treatable by suppression of the JAK/STAT pathway.

Use of apoptosis-specific EIF-5A sirnas for the manufacture of a medicament for use in the treatment of a disease treatable by suppression of the JAK/STAT pathway.

机译：凋亡特异性EIF-5A sirnas在制备用于治疗可通过抑制JAK / STAT途径治疗的疾病的药物中的用途。

页面导航

摘要
著录项
相似文献

摘要

Disclosed is the use of an siRNA of an apoptosis specific eIF-5A in the manufacture of a medicament for use in the treatment of a condition treatable by suppression of the activation of the JAAK/STAT pathway, wherein said siRNA suppresses activation of the JAK/STAT pathway in a cell.

机译：公开了凋亡特异性eIF-5A的siRNA在制备药物中的用途，所述药物用于治疗可通过抑制JAAK / STAT途径的激活而治疗的疾病，其中所述siRNA抑制JAK / STAT的激活。细胞中的STAT途径。

著录项

公开/公告号NZ552692A

专利类型
公开/公告日2010-08-27

原文格式PDF
申请/专利权人 SENESCO TECHNOLOGIES INC.;
展开▼

申请/专利号NZ20050552692
发明设计人 THOMPSON JOHN E;GALTON BRUCE C;DINARELLO CHARLES;BOONE ADRIENNE;TAYLOR CATHERINE;REZNIKOV LEONID;HOPKINS MARIANNE;
展开▼

申请日2005-07-20
分类号A61P11;A61K31/713;C12N15/113;
国家 NZ
入库时间 2022-08-21 18:45:27

相似文献

专利
外文文献
中文文献